The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Hypofractionated (HRT) versus standard (SRT) radiotherapy with or without temozolomide (T) for elderly patients with glioblastoma (GBM).
Shyam Kumar Tanguturi
No relevant relationships to disclose
Patrick Y. Wen
No relevant relationships to disclose
David A. Reardon
No relevant relationships to disclose
Eudocia Quant Lee
No relevant relationships to disclose
Lakshmi Nayak
No relevant relationships to disclose
Laura W Christianson
No relevant relationships to disclose
Margaret C Horvath
No relevant relationships to disclose
Ian F. Dunn
No relevant relationships to disclose
Alexandra J Golby
Stock Ownership - Merck
Mark D Johnson
No relevant relationships to disclose
Elizabeth B Claus
No relevant relationships to disclose
E. Antonio Chiocca
No relevant relationships to disclose
Keith L. Ligon
No relevant relationships to disclose
Brian Michael Alexander
No relevant relationships to disclose
Nils D. Arvold
No relevant relationships to disclose